Lululemon (LULU) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

In a report released today, Joseph Civello from Truist Financial assigned a Buy rating to Lululemon Athletica (LULU – Research Report).

Needham cut Apellis Pharmaceuticals, Inc. APLS price target from $85 to $60. Needham analyst Joseph Stringer maintained a Buy ...

Read the original article on Purewow. The holidays are creeping up fast, and if you’re anything like me, that means the ...